Clinical Trial Update: Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing bendamustine plus rituximab versus fludarabine plus rituximab in non-Hodgkin's lymphoma and mantle cell lymphoma has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: University of Giessen | Conditions: Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma | Phase 3 | Status: COMPLETED